Neonates born prematurely (< 37 weeks of gestation) are at a significantly increased risk of
developing inflammatory conditions associated with high mortality rates, including …

Neonatal hypoxic–ischemic brain injury (HIBI) is a devastating injury resulting from impaired
blood flow and oxygen delivery to the brain at or around the time of birth. Despite the use of …

Hypoglycemia has been recognized as a risk factor for diabetic vascular complications and
cognitive decline, but the molecular mechanisms of the effect of hypoglycemia on target …

This study's purpose was to confirm the observed underexpression of miRNA-410 in glioma
tissues and several glioma cells by Quantitative RT-PCR. Our findings suggest that …

Translation of neuroprotective treatment effects from experimental animal models to patients
with cerebral ischemia has been challenging. Since pathophysiological processes may vary …

Hypoxia and ischemia cause inflammatory injury and critically participate in the
pathogenesis of various diseases in various organs. However, the protective strategies …

Background Neonatal hypoxic-ischemic encephalopathy (HIE), a kind of hypoxic-ischemic
brain damage caused by perinatal asphyxia, is the most crucial cause of neonatal death and …

The purpose of this study was to identify the target genes of tcon_00044595, elucidate its
activation site, and provide novel insights into the pathogenesis and treatment of neonatal …

Aim This study aimed to explore whether microRNAs (miRNAs) could serve as biomarkers of
perinatal asphyxia and whether they were correlated with severity of brain magnetic …

Background: MicroRNAs (miRNAs) may be promising therapeutic targets for neonatal
hypoxic-ischemic brain injury (HIBI) but targeting miRNA-based therapy will require more …